Charles B O'Keeffe Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

CPRX Quotes by TradingView

Charles B O'Keeffe is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 685,724 shares of CPRX, which is worth approximately $15.1 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 4,000 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 686K
0% 3M change
10.53% 12M change
Total Value Held $15.1 Million

Charles B O'Keeffe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
4,000 Added 0.58%
685,724 Common Stock, par valu...
Jan 02 2024
BUY
Exercise of conversion of derivative security
$67,800 $1.13 p/Share
60,000 Added 8.09%
681,724 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.21%
621,724 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
4,000 Added 0.64%
620,391 Common Stock, par valu...
Jan 24 2023
BUY
Exercise of conversion of derivative security
$39,500 $0.79 p/Share
50,000 Added 7.5%
616,391 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
1,334 Added 0.23%
566,391 Common Stock, par valu...
Nov 15 2022
BUY
Open market or private sale
$1,411,279 $16.04 p/Share
87,985 Added 13.47%
565,057 Common Stock, par valu...
Aug 18 2022
BUY
Exercise of conversion of derivative security
$101,200 $2.53 p/Share
40,000 Added 5.77%
653,042 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.22%
613,042 Common Stock, par valu...
Aug 16 2021
BUY
Exercise of conversion of derivative security
$156,000 $3.12 p/Share
50,000 Added 7.56%
611,709 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.24%
561,709 Common Stock, par valu...
Sep 30 2020
BUY
Open market or private purchase
$20,930 $2.99 p/Share
7,000 Added 1.23%
560,376 Common Stock, par valu...
CBO

Charles B O'Keeffe

Director
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CPRX